×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
上海药物研究所 [4]
合肥物质科学研究院 [2]
自动化研究所 [1]
近代物理研究所 [1]
内容类型
期刊论文 [8]
发表日期
2021 [8]
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共8条,第1-8条
帮助
限定条件
发表日期:2021
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
A Support Vector Machine Based on Liquid Immune Profiling Predicts Major Pathological Response to Chemotherapy Plus Anti-PD-1/PD-L1 as a Neoadjuvant Treatment for Patients With Resectable Non-Small Cell Lung Cancer
期刊论文
FRONTIERS IN IMMUNOLOGY, 2021, 卷号: 12
作者:
Peng, Jie
;
Zou, Dan
;
Han, Lijie
;
Yin, Zuomin
;
Hu, Xiao
收藏
  |  
浏览/下载:22/0
  |  
提交时间:2022/02/14
non-small cell lung cancer
support vector machine
major pathological response
liquid immune profiling
neoadjuvant treatment
Engineering Chameleon Prodrug Nanovesicles to Increase Antigen Presentation and Inhibit PD-L1 Expression for Circumventing Immune Resistance of Cancer
期刊论文
ADVANCED MATERIALS, 2021, 页码: 12
作者:
Zhou, Fengqi
;
Gao, Jing
;
Tang, Yang
;
Zou, Zhifeng
;
Jiao, Shi
收藏
  |  
浏览/下载:37/0
  |  
提交时间:2021/11/04
antigen presentation
autophagy inhibition
immune resistance
immunotherapy
prodrug nanovesicles
Acid-activatible micelleplex delivering siRNA-PD-L1 for improved cancer immunotherapy of CDK4/6 inhibition
期刊论文
CHINESE CHEMICAL LETTERS, 2021, 卷号: 32, 期号: 6, 页码: 1929-1936
作者:
Gao, Jing
;
Zhang, Hanwu
;
Zhou, Fengqi
;
Hou, Bo
;
Chen, Meiwan
收藏
  |  
浏览/下载:17/0
  |  
提交时间:2021/08/17
Cancer immunotherapy
siRNA delivery
Acid-activatible micelleplex
CDK4
6 inhibitor
PD-L1 knockdown
AdvanTIG-302: Anti-TIGIT monoclonal antibody (mAb) ociperlimab (OCI) plus tislelizumab (TIS) versus pembrolizumab (PEM) in programmed death ligand-1 (PD-L1) selected, previously untreated, locally advanced, unresectable or metastatic non-small cell lung cancer (NSCLC).
期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:
Socinski, Mark A.
;
Spira, Alexander I.
;
Paz-Ares, Luis G.
;
Reck, Martin
;
Lu, Shun
收藏
  |  
浏览/下载:31/0
  |  
提交时间:2022/01/10
Engineering Oxaliplatin Prodrug Nanoparticles for Second Near-Infrared Fluorescence Imaging-Guided Immunotherapy of Colorectal Cancer
期刊论文
SMALL, 2021, 卷号: 17, 期号: 13, 页码: 11
作者:
Zhu, Qiurong
;
Sun, Fang
;
Li, Tianliang
;
Zhou, Mengxue
;
Ye, Jiayi
收藏
  |  
浏览/下载:108/0
  |  
提交时间:2021/05/24
colorectal cancer
combinatory immunotherapy
immunogenic cell death
prodrug nanoparticles
second near‐
infrared fluorescence imaging
Overcoming immune resistance by sequential prodrug nanovesicles for promoting chemoimmunotherapy of cancer
期刊论文
NANO TODAY, 2021, 卷号: 36, 页码: 12
作者:
Zhou, Fengqi
;
Gao, Jing
;
Xu, Zhiai
;
Li, Tianliang
;
Gao, Ang
收藏
  |  
浏览/下载:24/0
  |  
提交时间:2021/06/11
Tumor microenvironment
Prodrug nanovesicles
Cancer immunotherapy
Immunogenic cell death
Adaptive immune resistance
Safety and efficacy of combination therapy using programmed cell death protein-1/programmed cell death ligand-1 inhibitors and radiotherapy in patients with non-small-cell lung cancer: A systematic review and meta-analysis
期刊论文
CANCER MEDICINE, 2021, 页码: 19
作者:
Geng, Yichao
;
Zhang, Qiuning
;
Feng, Shuangwu
;
Li, Chengcheng
;
Wang, Lina
收藏
  |  
浏览/下载:26/0
  |  
提交时间:2021/12/10
combined radio-immunotherapy
meta-analysis
non-small-cell lung cancer
programmed cell death protein-1/programmed cell death ligand-1 inhibitors
radiotherapy
systematic review
Non-invasive measurement of PD-L1 status and prediction of immunotherapy response using deep learning of PET/CT images
期刊论文
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 卷号: 9, 期号: 6, 页码: 15
作者:
Mu, Wei
;
Jiang, Lei
;
Shi, Yu
;
Tunali, Ilke
;
Gray, Jhanelle E.
收藏
  |  
浏览/下载:71/0
  |  
提交时间:2021/08/15
tumor biomarkers
immunotherapy
©版权所有 ©2017 CSpace - Powered by
CSpace